Peptidases present in central nervous system (CNS) synaptic membranes, hydrolyze the neuroactive peptide cholecystokinin-octapeptide (CCK-8; Asp-Tyr-SO3H-Met-Gly-Trp-Met-Asp-Phe-NH2). In order to determine the pathway of degradation, synthetic CCK-8 was incubated at 37°C with purified synaptic membranes; at various intervals reaction samples were removed from the reaction mixture and analysed by high-performance liquid chromatography to identify and quantify the peptide fragments. The results indicate an initial endopeptidase cleavage at the Met-Gly bond producing CCK-5 (Gly-Trp-Met-Asp-Phe-NH2). The carboxyl-terminal pentapeptide is further proteolysed to CCK-4 (Trp-Met-Asp-Phe-NH2) by a puromycin-sensitive aminopeptidase and to CCK-3 (Met...
In this thesis the in vitro release of immunoreactive CCK₈ (iCCK₈) from rat central nervous system p...
1. A scheme of synthesis was developped for cholecystokinin (CCK) 26-33, using solid-phase methodolo...
There are three levels at which biologically active peptides may be regulated: transcription, transl...
Based on recent findings identifying the initial degradative cleavage of CCK-8 at the Met3-Gly4 bond...
Solubilization of rat synaptic membranes by Triton X-100 followed by DEAE-cellulose chromatography a...
AbstractAs the C-terminal octapeptide of cholecystokinin represents a putative neurotransmitter in t...
Structural determinants of cholecystokinin octapeptide (CCK-8) binding to central nervous system rec...
Rat kidney membranes were solubilized by Triton X-100 and the CCK-8 degrading peptidases were resolv...
Inactivation of cholecystokinin octapeptide in vitro involves a metalloendopeptidase (EC 3.4.24.11) ...
Given the high resistance of the cholecystokinin octapeptide (CCK8) to in vivo peptidase degradation...
The role of aminopeptidase A (APA) in inactivating cholecystokinin (CCK-8) was investigated in in vi...
AbstractEndopeptidase-24.11 (EC 3.4.24.11) from pig kidney hydrolysed CCK-8 (sulphated) at two disti...
Crude extracts of porcine cerebral cortical tissue convert cholecystokinin (CCK) to its COOH-termina...
Research on digestive peptides in brain started in 1975 with the discovery of peptides of the gastri...
Introduction Cholecystokinin, CCK was first isolated from porcine intestine by Mutt and Jorpes at t...
In this thesis the in vitro release of immunoreactive CCK₈ (iCCK₈) from rat central nervous system p...
1. A scheme of synthesis was developped for cholecystokinin (CCK) 26-33, using solid-phase methodolo...
There are three levels at which biologically active peptides may be regulated: transcription, transl...
Based on recent findings identifying the initial degradative cleavage of CCK-8 at the Met3-Gly4 bond...
Solubilization of rat synaptic membranes by Triton X-100 followed by DEAE-cellulose chromatography a...
AbstractAs the C-terminal octapeptide of cholecystokinin represents a putative neurotransmitter in t...
Structural determinants of cholecystokinin octapeptide (CCK-8) binding to central nervous system rec...
Rat kidney membranes were solubilized by Triton X-100 and the CCK-8 degrading peptidases were resolv...
Inactivation of cholecystokinin octapeptide in vitro involves a metalloendopeptidase (EC 3.4.24.11) ...
Given the high resistance of the cholecystokinin octapeptide (CCK8) to in vivo peptidase degradation...
The role of aminopeptidase A (APA) in inactivating cholecystokinin (CCK-8) was investigated in in vi...
AbstractEndopeptidase-24.11 (EC 3.4.24.11) from pig kidney hydrolysed CCK-8 (sulphated) at two disti...
Crude extracts of porcine cerebral cortical tissue convert cholecystokinin (CCK) to its COOH-termina...
Research on digestive peptides in brain started in 1975 with the discovery of peptides of the gastri...
Introduction Cholecystokinin, CCK was first isolated from porcine intestine by Mutt and Jorpes at t...
In this thesis the in vitro release of immunoreactive CCK₈ (iCCK₈) from rat central nervous system p...
1. A scheme of synthesis was developped for cholecystokinin (CCK) 26-33, using solid-phase methodolo...
There are three levels at which biologically active peptides may be regulated: transcription, transl...